By vgreene, 24 February, 2020 D c romosozumab and start other antiresorptive tx BPs denosumab have strongest evidence
By vgreene, 21 February, 2020 Dengue virus infxn more likely to cause neutropenia, thrombocytopenia, hemorrhage, shock and death
By vgreene, 21 February, 2020 Chikungunya virus infxn more likely to cause high fever, severe arthralgia, arthritis, rash, and lymphopenia
By vgreene, 21 February, 2020 R/o dengue virus infxn; otherwise, manage pts w/ suspected chikungunya as dengue until dengue has been r/o to reduce risk of medical complications/death:4
By vgreene, 21 February, 2020 Criteria to guide eval of persons suspected of chikungunya virus<sup>4-6</sup>